Kuehne + Nagel International (OTCMKTS:KHNGY - Get Free Report) will likely be issuing its quarterly earnings data on Thursday, March 6th. Analysts expect the company to announce earnings of $0.61 per share and revenue of $6.08 billion for the quarter.
Kuehne + Nagel International Trading Up 0.5 %
Kuehne + Nagel International stock traded up $0.22 during midday trading on Friday, reaching $45.93. The company's stock had a trading volume of 23,380 shares, compared to its average volume of 35,307. The stock has a market cap of $27.73 billion, a PE ratio of 20.97 and a beta of 0.84. Kuehne + Nagel International has a 52 week low of $43.66 and a 52 week high of $67.50. The business has a 50-day moving average price of $45.65 and a 200-day moving average price of $50.13.
About Kuehne + Nagel International
(
Get Free Report)
Kuehne + Nagel International AG, together with its subsidiaries, provides integrated logistics services worldwide. The company operates through four segments: Sea Logistics, Air Logistics, Road Logistics, and Contract Logistics. It offers less-than-container load, reefer and project logistics, and flexible container shipping solutions.
Read More
Before you consider Kuehne + Nagel International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kuehne + Nagel International wasn't on the list.
While Kuehne + Nagel International currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
